Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Colombias Grupo Biotoscana buys Argentine Laboratorio LKM

Grupo Biotoscana SL, a leading specialty pharmaceutical company in Latin America, announced that it has completed the acquisition of Laboratorio LKM S.A., a specialty pharmaceutical manufacturer based in Argentina. The transaction creates the first biopharmaceutical company in Latin America with a truly pan-regional presence and focus on specialty pharmaceuticals. Financial terms of the transaction were not disclosed. The company will operate under the Biotoscana, United Medical and LKM brands. Biotoscana is controlled by global private equity firm Advent International, with other significant shareholders including Essex Woodlands and a number of private investors. The company operates in some of the fastest-growing Latin American economies, such as Brazil, Colombia, Peru, Chile and Argentina, and focuses on rapidly- growing market segments, such as oncology, infectious diseases, hematology, genetic disorders, HIV and rare diseases.


PE Deals,Advent International,Grupo Biotoscana SL,Laboratorio LKM